Cargando…
Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children
The purpose of this study was to determine the efficacy of inhaled epoprostenol for treatment of acute pulmonary hypertension (PH) in pediatric patients and to formulate a plan for a prospective, randomized study of pulmonary vasodilator therapy in this population. Inhaled epoprostenol is an effecti...
Autores principales: | Brown, Anna T., Gillespie, Jennifer V., Miquel-Verges, Franscesca, Holmes, Kathryn, Ravekes, William, Spevak, Philip, Brady, Ken, Easley, R. Blaine, Golden, W. Christopher, McNamara, LeAnn, Veltri, Michael A., Lehmann, Christoph U., McMillan, Kristen Nelson, Schwartz, Jamie M., Romer, Lewis H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342750/ https://www.ncbi.nlm.nih.gov/pubmed/22558521 http://dx.doi.org/10.4103/2045-8932.94835 |
Ejemplares similares
-
Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020) -
Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19
por: Sonti, Rajiv, et al.
Publicado: (2020) -
HIGH-FLOW NASAL CANULA AND INHALED EPOPROSTENOL RESPONSE IN COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2022) -
Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension
por: Preston, Ioana R., et al.
Publicado: (2013) -
Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)